Skip to content

Aura Biosciences, Inc. AURA Cash Flow Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
-$112.39M-5.8%-$106.19M+0.3%-$106.47M-5.0%-$101.38M-7.1%-$94.7M-8.9%
$1.15M-1.5%$1.16M-1.6%$1.18M0.0%$1.18M0.0%$1.18M-1.3%
$14.63M+2.2%$14.32M+2.5%$13.97M+7.2%$13.03M+5.7%$12.33M+5.2%
-$91.28M-7.7%-$84.74M+3.9%-$88.23M-5.8%-$83.35M-5.9%-$78.71M+1.4%
$362K-19.0%$447K-21.6%$570K-34.2%$866K-35.9%$1.35M+7.9%
$89.37M+0.2%$89.24M+29.7%
$77.36M+0.3%$77.16M+3.0%$74.93M+5.1%$71.28M+4,857%$1.44M-9.8%
-$91.64M-7.6%-$85.19M+4.1%-$88.8M-5.4%-$84.22M-5.2%-$80.06M+1.2%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Aura Biosciences, Inc. generate?
Aura Biosciences, Inc. (AURA) generated -$91.3M in operating cash flow over the trailing twelve months.
What is Aura Biosciences, Inc.'s free cash flow?
After $362.0K of capital expenditures, Aura Biosciences, Inc.'s free cash flow was -$91.6M over the trailing twelve months, down 14.5% year over year.
Where does Aura Biosciences, Inc.'s cash flow data come from?
Every line is extracted from Aura Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.